 | • レポートコード：MRC2012B0477 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、HIV診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。HIV診断の種類別市場規模（抗体検査、ウイルス量検査、CD4検査、乳児早期診断検査、ウイルス同定検査）、用途別市場規模（診断研究所、病院、血液銀行、在宅医療施設、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Siemens Healthineers、Hologic、Beckman Coulter、Roche Diagnostics、Becton, Dickinson、Abbott Laboratories、Bio-Rad Laboratories、Merck、Thermo Fisher、Abbott、 ・地域別グローバル市場分析 2015年-2020年 ・HIV診断の北米市場（アメリカ、カナダ、メキシコ） ・HIV診断のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・HIV診断のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・HIV診断の南米市場（ブラジル、アルゼンチン） ・HIV診断の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：抗体検査、ウイルス量検査、CD4検査、乳児早期診断検査、ウイルス同定検査 ・用途別分析：診断研究所、病院、血液銀行、在宅医療施設、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global HIV Diagnosis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.1% in the forecast period of 2020 to 2025 and will expected to reach USD 3709.4 million by 2025, from USD 2712.5 million in 2019.
The HIV Diagnosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
HIV Diagnosis market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, HIV Diagnosis market has been segmented into:
Antibody Tests
Viral Load Tests
CD4 Tests
Tests for Early Infant Diagnosis
Tests for Viral Identification
By Application, HIV Diagnosis has been segmented into:
Diagnostic Laboratories
Hospitals
Blood Banks
Home Care Settings
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global HIV Diagnosis market presented in the report. This section sheds light on the sales growth of different regional and country-level HIV Diagnosis markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global HIV Diagnosis market.
The report offers in-depth assessment of the growth and other aspects of the HIV Diagnosis market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and HIV Diagnosis Market Share Analysis
HIV Diagnosis competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, HIV Diagnosis sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the HIV Diagnosis sales, revenue and market share for each player covered in this report.
The major players covered in HIV Diagnosis are:
Siemens Healthineers
Hologic
Beckman Coulter
Roche Diagnostics
Becton, Dickinson
Abbott Laboratories
Bio-Rad Laboratories
Merck
Thermo Fisher
Abbott
Table of Contents
1 HIV Diagnosis Market Overview
1.1 Product Overview and Scope of HIV Diagnosis
1.2 Classification of HIV Diagnosis by Type
1.2.1 Global HIV Diagnosis Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global HIV Diagnosis Revenue Market Share by Type in 2019
1.2.3 Antibody Tests
1.2.4 Viral Load Tests
1.2.5 CD4 Tests
1.2.6 Tests for Early Infant Diagnosis
1.2.7 Tests for Viral Identification
1.3 Global HIV Diagnosis Market by Application
1.3.1 Overview: Global HIV Diagnosis Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.3.4 Blood Banks
1.3.5 Home Care Settings
1.3.6 Others
1.4 Global HIV Diagnosis Market by Regions
1.4.1 Global HIV Diagnosis Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of HIV Diagnosis (2015-2025)
1.4.3 North America (USA, Canada and Mexico) HIV Diagnosis Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) HIV Diagnosis Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) HIV Diagnosis Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) HIV Diagnosis Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) HIV Diagnosis Status and Prospect (2015-2025)
2 Company Profiles
2.1 Siemens Healthineers
2.1.1 Siemens Healthineers Details
2.1.2 Siemens Healthineers Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Siemens Healthineers SWOT Analysis
2.1.4 Siemens Healthineers Product and Services
2.1.5 Siemens Healthineers HIV Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.2 Hologic
2.2.1 Hologic Details
2.2.2 Hologic Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Hologic SWOT Analysis
2.2.4 Hologic Product and Services
2.2.5 Hologic HIV Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.3 Beckman Coulter
2.3.1 Beckman Coulter Details
2.3.2 Beckman Coulter Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Beckman Coulter SWOT Analysis
2.3.4 Beckman Coulter Product and Services
2.3.5 Beckman Coulter HIV Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche Diagnostics
2.4.1 Roche Diagnostics Details
2.4.2 Roche Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche Diagnostics SWOT Analysis
2.4.4 Roche Diagnostics Product and Services
2.4.5 Roche Diagnostics HIV Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.5 Becton, Dickinson
2.5.1 Becton, Dickinson Details
2.5.2 Becton, Dickinson Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Becton, Dickinson SWOT Analysis
2.5.4 Becton, Dickinson Product and Services
2.5.5 Becton, Dickinson HIV Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.6 Abbott Laboratories
2.6.1 Abbott Laboratories Details
2.6.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Abbott Laboratories SWOT Analysis
2.6.4 Abbott Laboratories Product and Services
2.6.5 Abbott Laboratories HIV Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bio-Rad Laboratories
2.7.1 Bio-Rad Laboratories Details
2.7.2 Bio-Rad Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bio-Rad Laboratories SWOT Analysis
2.7.4 Bio-Rad Laboratories Product and Services
2.7.5 Bio-Rad Laboratories HIV Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Merck SWOT Analysis
2.8.4 Merck Product and Services
2.8.5 Merck HIV Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.9 Thermo Fisher
2.9.1 Thermo Fisher Details
2.9.2 Thermo Fisher Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Thermo Fisher SWOT Analysis
2.9.4 Thermo Fisher Product and Services
2.9.5 Thermo Fisher HIV Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.10 Abbott
2.10.1 Abbott Details
2.10.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Abbott SWOT Analysis
2.10.4 Abbott Product and Services
2.10.5 Abbott HIV Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global HIV Diagnosis Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 HIV Diagnosis Players Market Share
3.2.2 Top 10 HIV Diagnosis Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global HIV Diagnosis Revenue and Market Share by Regions
4.2 North America HIV Diagnosis Revenue and Growth Rate (2015-2020)
4.3 Europe HIV Diagnosis Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific HIV Diagnosis Revenue and Growth Rate (2015-2020)
4.5 South America HIV Diagnosis Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa HIV Diagnosis Revenue and Growth Rate (2015-2020)
5 North America HIV Diagnosis Revenue by Countries
5.1 North America HIV Diagnosis Revenue by Countries (2015-2020)
5.2 USA HIV Diagnosis Revenue and Growth Rate (2015-2020)
5.3 Canada HIV Diagnosis Revenue and Growth Rate (2015-2020)
5.4 Mexico HIV Diagnosis Revenue and Growth Rate (2015-2020)
6 Europe HIV Diagnosis Revenue by Countries
6.1 Europe HIV Diagnosis Revenue by Countries (2015-2020)
6.2 Germany HIV Diagnosis Revenue and Growth Rate (2015-2020)
6.3 UK HIV Diagnosis Revenue and Growth Rate (2015-2020)
6.4 France HIV Diagnosis Revenue and Growth Rate (2015-2020)
6.5 Russia HIV Diagnosis Revenue and Growth Rate (2015-2020)
6.6 Italy HIV Diagnosis Revenue and Growth Rate (2015-2020)
7 Asia-Pacific HIV Diagnosis Revenue by Countries
7.1 Asia-Pacific HIV Diagnosis Revenue by Countries (2015-2020)
7.2 China HIV Diagnosis Revenue and Growth Rate (2015-2020)
7.3 Japan HIV Diagnosis Revenue and Growth Rate (2015-2020)
7.4 Korea HIV Diagnosis Revenue and Growth Rate (2015-2020)
7.5 India HIV Diagnosis Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia HIV Diagnosis Revenue and Growth Rate (2015-2020)
8 South America HIV Diagnosis Revenue by Countries
8.1 South America HIV Diagnosis Revenue by Countries (2015-2020)
8.2 Brazil HIV Diagnosis Revenue and Growth Rate (2015-2020)
8.3 Argentina HIV Diagnosis Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue HIV Diagnosis by Countries
9.1 Middle East & Africa HIV Diagnosis Revenue by Countries (2015-2020)
9.2 Saudi Arabia HIV Diagnosis Revenue and Growth Rate (2015-2020)
9.3 UAE HIV Diagnosis Revenue and Growth Rate (2015-2020)
9.4 Egypt HIV Diagnosis Revenue and Growth Rate (2015-2020)
9.5 South Africa HIV Diagnosis Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global HIV Diagnosis Revenue and Market Share by Type (2015-2020)
10.2 Global HIV Diagnosis Market Forecast by Type (2019-2024)
10.3 Antibody Tests Revenue Growth Rate (2015-2025)
10.4 Viral Load Tests Revenue Growth Rate (2015-2025)
10.5 CD4 Tests Revenue Growth Rate (2015-2025)
10.6 Tests for Early Infant Diagnosis Revenue Growth Rate (2015-2025)
10.7 Tests for Viral Identification Revenue Growth Rate (2015-2025)
11 Global HIV Diagnosis Market Segment by Application
11.1 Global HIV Diagnosis Revenue Market Share by Application (2015-2020)
11.2 HIV Diagnosis Market Forecast by Application (2019-2024)
11.3 Diagnostic Laboratories Revenue Growth (2015-2020)
11.4 Hospitals Revenue Growth (2015-2020)
11.5 Blood Banks Revenue Growth (2015-2020)
11.6 Home Care Settings Revenue Growth (2015-2020)
11.7 Others Revenue Growth (2015-2020)
12 Global HIV Diagnosis Market Size Forecast (2021-2025)
12.1 Global HIV Diagnosis Market Size Forecast (2021-2025)
12.2 Global HIV Diagnosis Market Forecast by Regions (2021-2025)
12.3 North America HIV Diagnosis Revenue Market Forecast (2021-2025)
12.4 Europe HIV Diagnosis Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific HIV Diagnosis Revenue Market Forecast (2021-2025)
12.6 South America HIV Diagnosis Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa HIV Diagnosis Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global HIV Diagnosis Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of HIV Diagnosis by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global HIV Diagnosis Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market HIV Diagnosis Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Siemens Healthineers Corporate Information, Location and Competitors
Table 6. Siemens Healthineers HIV Diagnosis Major Business
Table 7. Siemens Healthineers HIV Diagnosis Total Revenue (USD Million) (2017-2018)
Table 8. Siemens Healthineers SWOT Analysis
Table 9. Siemens Healthineers HIV Diagnosis Product and Solutions
Table 10. Siemens Healthineers HIV Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Hologic Corporate Information, Location and Competitors
Table 12. Hologic HIV Diagnosis Major Business
Table 13. Hologic HIV Diagnosis Total Revenue (USD Million) (2018-2019)
Table 14. Hologic SWOT Analysis
Table 15. Hologic HIV Diagnosis Product and Solutions
Table 16. Hologic HIV Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Beckman Coulter Corporate Information, Location and Competitors
Table 18. Beckman Coulter HIV Diagnosis Major Business
Table 19. Beckman Coulter HIV Diagnosis Total Revenue (USD Million) (2017-2018)
Table 20. Beckman Coulter SWOT Analysis
Table 21. Beckman Coulter HIV Diagnosis Product and Solutions
Table 22. Beckman Coulter HIV Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Roche Diagnostics Corporate Information, Location and Competitors
Table 24. Roche Diagnostics HIV Diagnosis Major Business
Table 25. Roche Diagnostics HIV Diagnosis Total Revenue (USD Million) (2017-2018)
Table 26. Roche Diagnostics SWOT Analysis
Table 27. Roche Diagnostics HIV Diagnosis Product and Solutions
Table 28. Roche Diagnostics HIV Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Becton, Dickinson Corporate Information, Location and Competitors
Table 30. Becton, Dickinson HIV Diagnosis Major Business
Table 31. Becton, Dickinson HIV Diagnosis Total Revenue (USD Million) (2017-2018)
Table 32. Becton, Dickinson SWOT Analysis
Table 33. Becton, Dickinson HIV Diagnosis Product and Solutions
Table 34. Becton, Dickinson HIV Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Abbott Laboratories Corporate Information, Location and Competitors
Table 36. Abbott Laboratories HIV Diagnosis Major Business
Table 37. Abbott Laboratories HIV Diagnosis Total Revenue (USD Million) (2017-2018)
Table 38. Abbott Laboratories SWOT Analysis
Table 39. Abbott Laboratories HIV Diagnosis Product and Solutions
Table 40. Abbott Laboratories HIV Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Bio-Rad Laboratories Corporate Information, Location and Competitors
Table 42. Bio-Rad Laboratories HIV Diagnosis Major Business
Table 43. Bio-Rad Laboratories HIV Diagnosis Total Revenue (USD Million) (2017-2018)
Table 44. Bio-Rad Laboratories SWOT Analysis
Table 45. Bio-Rad Laboratories HIV Diagnosis Product and Solutions
Table 46. Bio-Rad Laboratories HIV Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Merck Corporate Information, Location and Competitors
Table 48. Merck HIV Diagnosis Major Business
Table 49. Merck HIV Diagnosis Total Revenue (USD Million) (2017-2018)
Table 50. Merck SWOT Analysis
Table 51. Merck HIV Diagnosis Product and Solutions
Table 52. Merck HIV Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Thermo Fisher Corporate Information, Location and Competitors
Table 54. Thermo Fisher HIV Diagnosis Major Business
Table 55. Thermo Fisher HIV Diagnosis Total Revenue (USD Million) (2017-2018)
Table 56. Thermo Fisher SWOT Analysis
Table 57. Thermo Fisher HIV Diagnosis Product and Solutions
Table 58. Thermo Fisher HIV Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Abbott Corporate Information, Location and Competitors
Table 60. Abbott HIV Diagnosis Major Business
Table 61. Abbott HIV Diagnosis Total Revenue (USD Million) (2017-2018)
Table 62. Abbott SWOT Analysis
Table 63. Abbott HIV Diagnosis Product and Solutions
Table 64. Abbott HIV Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global HIV Diagnosis Revenue (Million USD) by Players (2015-2020)
Table 66. Global HIV Diagnosis Revenue Share by Players (2015-2020)
Table 67. Global HIV Diagnosis Revenue (Million USD) by Regions (2015-2020)
Table 68. Global HIV Diagnosis Revenue Market Share by Regions (2015-2020)
Table 69. North America HIV Diagnosis Revenue by Countries (2015-2020)
Table 70. North America HIV Diagnosis Revenue Market Share by Countries (2015-2020)
Table 71. Europe HIV Diagnosis Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific HIV Diagnosis Revenue (Million USD) by Countries (2015-2020)
Table 73. South America HIV Diagnosis Revenue by Countries (2015-2020)
Table 74. South America HIV Diagnosis Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa HIV Diagnosis Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa HIV Diagnosis Revenue Market Share by Countries (2015-2020)
Table 77. Global HIV Diagnosis Revenue (Million USD) by Type (2015-2020)
Table 78. Global HIV Diagnosis Revenue Share by Type (2015-2020)
Table 79. Global HIV Diagnosis Revenue Forecast by Type (2021-2025)
Table 80. Global HIV Diagnosis Revenue by Application (2015-2020)
Table 81. Global HIV Diagnosis Revenue Share by Application (2015-2020)
Table 82. Global HIV Diagnosis Revenue Forecast by Application (2021-2025)
Table 83. Global HIV Diagnosis Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. HIV Diagnosis Picture
Figure 2. Global HIV Diagnosis Revenue Market Share by Type in 2019
Figure 3. Antibody Tests Picture
Figure 4. Viral Load Tests Picture
Figure 5. CD4 Tests Picture
Figure 6. Tests for Early Infant Diagnosis Picture
Figure 7. Tests for Viral Identification Picture
Figure 8. HIV Diagnosis Revenue Market Share by Application in 2019
Figure 9. Diagnostic Laboratories Picture
Figure 10. Hospitals Picture
Figure 11. Blood Banks Picture
Figure 12. Home Care Settings Picture
Figure 13. Others Picture
Figure 14. Global HIV Diagnosis Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America HIV Diagnosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe HIV Diagnosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific HIV Diagnosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America HIV Diagnosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa HIV Diagnosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global HIV Diagnosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global HIV Diagnosis Revenue Share by Players in 2019
Figure 22. Global Top 5 Players HIV Diagnosis Revenue Market Share in 2019
Figure 23. Global Top 10 Players HIV Diagnosis Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global HIV Diagnosis Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global HIV Diagnosis Revenue Market Share by Regions (2015-2020)
Figure 27. Global HIV Diagnosis Revenue Market Share by Regions in 2018
Figure 28. North America HIV Diagnosis Revenue and Growth Rate (2015-2020)
Figure 29. Europe HIV Diagnosis Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific HIV Diagnosis Revenue and Growth Rate (2015-2020)
Figure 31. South America HIV Diagnosis Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa HIV Diagnosis Revenue and Growth Rate (2015-2020)
Figure 33. North America HIV Diagnosis Revenue Market Share by Countries (2015-2020)
Figure 34. North America HIV Diagnosis Revenue Market Share by Countries in 2019
Figure 35. USA HIV Diagnosis Revenue and Growth Rate (2015-2020)
Figure 36. Canada HIV Diagnosis Revenue and Growth Rate (2015-2020)
Figure 37. Mexico HIV Diagnosis Revenue and Growth Rate (2015-2020)
Figure 38. Europe HIV Diagnosis Revenue Market Share by Countries (2015-2020)
Figure 39. Europe HIV Diagnosis Revenue Market Share by Countries in 2019
Figure 40. Germany HIV Diagnosis Revenue and Growth Rate (2015-2020)
Figure 41. UK HIV Diagnosis Revenue and Growth Rate (2015-2020)
Figure 42. France HIV Diagnosis Revenue and Growth Rate (2015-2020)
Figure 43. Russia HIV Diagnosis Revenue and Growth Rate (2015-2020)
Figure 44. Italy HIV Diagnosis Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific HIV Diagnosis Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific HIV Diagnosis Revenue Market Share by Countries in 2019
Figure 47. China HIV Diagnosis Revenue and Growth Rate (2015-2020)
Figure 48. Japan HIV Diagnosis Revenue and Growth Rate (2015-2020)
Figure 49. Korea HIV Diagnosis Revenue and Growth Rate (2015-2020)
Figure 50. India HIV Diagnosis Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia HIV Diagnosis Revenue and Growth Rate (2015-2020)
Figure 52. South America HIV Diagnosis Revenue Market Share by Countries (2015-2020)
Figure 53. South America HIV Diagnosis Revenue Market Share by Countries in 2019
Figure 54. Brazil HIV Diagnosis Revenue and Growth Rate (2015-2020)
Figure 55. Argentina HIV Diagnosis Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa HIV Diagnosis Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa HIV Diagnosis Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia HIV Diagnosis Revenue and Growth Rate (2015-2020)
Figure 59. UAE HIV Diagnosis Revenue and Growth Rate (2015-2020)
Figure 60. Egypt HIV Diagnosis Revenue and Growth Rate (2015-2020)
Figure 61. South Africa HIV Diagnosis Revenue and Growth Rate (2015-2020)
Figure 62. Global HIV Diagnosis Revenue Share by Type (2015-2020)
Figure 63. Global HIV Diagnosis Revenue Share by Type in 2019
Figure 64. Global HIV Diagnosis Market Share Forecast by Type (2021-2025)
Figure 65. Global Antibody Tests Revenue Growth Rate (2015-2020)
Figure 66. Global Viral Load Tests Revenue Growth Rate (2015-2020)
Figure 67. Global CD4 Tests Revenue Growth Rate (2015-2020)
Figure 68. Global Tests for Early Infant Diagnosis Revenue Growth Rate (2015-2020)
Figure 69. Global Tests for Viral Identification Revenue Growth Rate (2015-2020)
Figure 70. Global HIV Diagnosis Revenue Share by Application (2015-2020)
Figure 71. Global HIV Diagnosis Revenue Share by Application in 2019
Figure 72. Global HIV Diagnosis Market Share Forecast by Application (2021-2025)
Figure 73. Global Diagnostic Laboratories Revenue Growth Rate (2015-2020)
Figure 74. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 75. Global Blood Banks Revenue Growth Rate (2015-2020)
Figure 76. Global Home Care Settings Revenue Growth Rate (2015-2020)
Figure 77. Global Others Revenue Growth Rate (2015-2020)
Figure 78. Global HIV Diagnosis Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global HIV Diagnosis Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global HIV Diagnosis Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America HIV Diagnosis Revenue Market Forecast (2021-2025)
Figure 82. Europe HIV Diagnosis Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific HIV Diagnosis Revenue Market Forecast (2021-2025)
Figure 84. South America HIV Diagnosis Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa HIV Diagnosis Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
関節リウマチ診断検査の世界市場（～2026年） Rheumatoid arthritis is a long-term autoimmune disorder that primarily affects joints. The goals of rheumatoid arthritis treatment are to reduce pain, decrease inflammation and improve a person's overall functioning. Market Analysis and Insights: Global Rheumatoid Arthritis Diagnosis Tests Market Th…- HIV診断・治療の世界市場（～2026年） HIV prevalence in Africa, specifically in Southern region is very high as compared to North African region. Approximately 1 out of 4 is suffering from HIV. Southern and Eastern region of Africa has one of the highest prevalence rate of HIV, about 19 million people have HIV. While HIV prevalence is l…
- 肝炎検査診断の世界市場（～2026年） Hepatitis is generally classified into two types based on the duration for which the patient suffers. If the condition lasts for less than six months, then it is classified as acute, when the condition persists for more than six months, then it is a case of chronic condition. Hepatitis testing refer…
- 結核診断・治療の世界市場（～2026年） An infectious disease caused by the bacterium Mycobacterium tuberculosis (MTB) is known as Tuberculosis (TB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. The rising screening rate in the high burden regions, faster clinical decisions, and affordability of d…
- 髄膜炎診断・治療の世界市場（～2026年） Meningitis is an acute inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges. The most common symptoms are fever, headache, and neck stiffness. Other symptoms include confusion or altered consciousness, vomiting, and an inability to tolerate …